GGrantIndex
Sort

17,828 grants matching crispr

Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity

$1,015,368
Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA

Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer

$1,015,048
A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2019 · CA

Targeting of somatic hypermutation in the genome

$1,013,870
David G. Schatz · Yale University · R01 · FY2025 · AI

Dynamic Structural Properties of Synapses

$1,013,053
Thomas S Reese · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

Laboratory of Oral Connective Tissue Biology

$1,012,894
Martha Somerman · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR

Targeting Pediatric Cancer Vulnerabilities

$1,012,869
Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2024 · CA

Research in Congenital Muscle Disease

$1,012,749
Katherine Meilleur · National Institute Of Nursing Research · ZIA · FY2018 · NR

Laboratory of Oral Connective Tissue Biology

$1,012,719
Martha Somerman · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR

Specification And Patterning of Developing Blood Vessels

$1,012,233
Brant Weinstein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

Red Cell Biology

$1,011,971
David M. Bodine · National Human Genome Research Institute · ZIA · FY2021 · HG

Project 2: Essential metabolic objectives of M. tuberculosis aerobiology

$1,011,608
Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI

Integrating targeted and immunotherapy to treat genetically heterogeneous cancers

$1,010,431
William A Weiss · University Of California, San Francisco · U01 · FY2020 · CA

Integrating targeted and immunotherapy to treat genetically heterogeneous cancers

$1,010,431
William A Weiss · University Of California, San Francisco · U01 · FY2018 · CA

Integrating targeted and immunotherapy to treat genetically heterogeneous cancers

$1,010,431
William A Weiss · University Of California, San Francisco · U01 · FY2021 · CA

Somatic Mosaicism in the Brain of Tourette Syndrome

$1,010,270
Flora M Vaccarino · Yale University · U01 · FY2016 · MH

Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases

$1,009,601
Calvin J Kuo · Stanford University · U19 · FY2015 · AI

Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression

$1,008,673
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer

$1,008,445
Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA

Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases

$1,007,943
Calvin J Kuo · Stanford University · U19 · FY2016 · AI

A Patient-Centric Approach to Advance Functional Precision Oncology

$1,007,878
Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2024 · CA

Functional decoding of signaling dynamics in single immune cells

$1,007,833
Myong-Hee Sung · National Institute On Aging · ZIA · FY2018 · AG

Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery

$1,007,803
Justin Kawika Ichida · University Of Southern California · R01 · FY2022 · NS

Genome instability in cancer: telomeres and DNA repair

$1,007,774
Titia De Lange · Rockefeller University · R35 · FY2023 · CA

Stanford Cooperative Research Center for Novel, Alternative Model Systems for Enteric Diseases

$1,006,235
Calvin J Kuo · Stanford University · U19 · FY2017 · AI

Targeting DNA Repair for Cancer Therapy.

$1,005,000
Peter M Glazer · Yale University · R35 · FY2025 · CA